Tag Archives: MorphoSys

MorphoSys Finalizes Delisting from Frankfurt and Nasdaq Markets Following Novartis Acquisition

(IN BRIEF) MorphoSys AG has completed its voluntary delisting from the Frankfurt Stock Exchange and Nasdaq Global Market following its acquisition by Novartis. The delisting agreement, announced on June 20, 2024, and the subsequent delisting purchase offer by Novartis were … Read the full press release